Error loading player: No playable sources found

2345

We Live in a Microbial World

Date
May 18, 2024

SOCIETY: AGA The session is dedicated to our outstanding mentor awardee, Dr. Rob Knight and the impact he has had on the field through his metorship.

Presentations:

PRESENTATION OF THE MICROBIOME & MICROBIAL THERAPY (MMT) SECTION RESEARCH MENTOR AWARD: ROB KNIGHT, PHD
HOW OUR MICROBES MAKE US WHO WE ARE
EVOLUTIONARY PERSPECTIVES ON DIET-MICROBIOME INTERACTIONS
VARIATION IN THE HUMAN GUT MICROBIOME
EFFECTS OF US IMMIGRATION AND DIET ON THE HUMAN MICROBIOME

Moderators

Speaker Image for Purna Kashyap
Mayo Clinic
Speaker Image for Suzanne Devkota
Cedars-Sinai Medical Center

Related Products

Thumbnail for AGA New Microbiome Mechanisms and Therapies: Complement, Cancer, and Customized Probiotics
AGA New Microbiome Mechanisms and Therapies: Complement, Cancer, and Customized Probiotics
The gut microbiome is implicated in a wide range of physiological processes, and holds great, but unrealized, potential for disease treatment and prevention…
Thumbnail for AGA FDA Town Hall
AGA FDA Town Hall
This session was jointly developed by AGA and representatives from the Division of Gastroenterology at the FDA Center for Drug Evaluation and Research…
Thumbnail for Breaking New Ground: Advancing Microbiome Therapeutics through Innovative Strategies
Breaking New Ground: Advancing Microbiome Therapeutics through Innovative Strategies
SOCIETY: AGA This session is focused on novel strategies for developing microbiome therapeutics including the use of synthetic communities, editing microbial communities using tools such as CRISPR and the use of phages as therapeutic tools…
Thumbnail for Microbiome & Microbial Therapy (MMT) Section Distinguished Abstract Plenary
Microbiome & Microbial Therapy (MMT) Section Distinguished Abstract Plenary
SOCIETY: AGA This session will feature a selection of the best abstracts submitted to the micobiome and microbial therapy section which encompass DGBI, IBD, cancer and liver disease…